Document Detail


Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents.
MedLine Citation:
PMID:  20803560     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Increasing evidence suggests that the presence of endotoxemia is of substantial clinical relevance to patients with cirrhosis, but it is unclear whether and how gut-derived LPS amplifies the tumorigenic response of the liver. We found that the circulating levels of LPS were elevated in animal models of carcinogen-induced hepatocarcinogenesis. Reduction of LPS using antibiotics regimen in rats or genetic ablation of its receptor Toll-like receptor 4 (TLR4) in mice prevented excessive tumor growth and multiplicity. Additional investigation revealed that TLR4 ablation sensitizes the liver to carcinogen-induced toxicity via blocking NF-κB activation and sensitizing the liver to reactive oxygen species (ROS)-induced toxicity, but lessens inflammation-mediated compensatory proliferation. Reconstitution of TLR4-expressing myeloid cells in TLR4-deficient mice restored diethylnitrosamine (DEN)-induced hepatic inflammation and proliferation, indicating a paracrine mechanism of LPS in tumor promotion. Meanwhile, deletion of gut-derived endotoxin suppressed DEN-induced cytokine production and compensatory proliferation, whereas in vivo LPS pre-challenge promotes hepatocyte proliferation. CONCLUSION: Our data indicate that sustained LPS accumulation represents a pathological mediator of inflammation-associated hepatocellular carcinoma (HCC) and manipulation of the gut flora to prevent pathogenic bacterial translocation and endotoxin absorption may favorably influence liver function in patients with cirrhosis who are at risk of developing HCC.
Authors:
Le-Xing Yu; He-Xin Yan; Qiong Liu; Wen Yang; Hong-Ping Wu; Wei Dong; Liang Tang; Yan Lin; Ya-Qin He; Shan-Shan Zou; Chao Wang; Hui-Lu Zhang; Guang-Wen Cao; Meng-Chao Wu; Hong-Yang Wang
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Hepatology (Baltimore, Md.)     Volume:  52     ISSN:  1527-3350     ISO Abbreviation:  Hepatology     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-29     Completed Date:  2010-10-18     Revised Date:  2011-09-09    
Medline Journal Info:
Nlm Unique ID:  8302946     Medline TA:  Hepatology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1322-33     Citation Subset:  IM    
Affiliation:
International Cooperation Laboratory on Signal Transduction, Liver Centre of SMMU, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apoptosis / drug effects*
Carcinogens / pharmacology*
Carcinoma, Hepatocellular / etiology*,  pathology
Cell Proliferation / drug effects
Diethylnitrosamine / toxicity
Intestines / microbiology
Lipopolysaccharides / blood,  pharmacology*
Liver Cirrhosis / complications
Liver Neoplasms / etiology*
Male
Mice
NF-kappa B / antagonists & inhibitors
Neomycin / pharmacology
Polymyxin B / pharmacology
Rats
Reactive Oxygen Species / pharmacology
Toll-Like Receptor 4 / physiology*
Chemical
Reg. No./Substance:
0/Carcinogens; 0/Lipopolysaccharides; 0/NF-kappa B; 0/Reactive Oxygen Species; 0/Tlr4 protein, mouse; 0/Toll-Like Receptor 4; 1404-04-2/Neomycin; 1404-26-8/Polymyxin B; 55-18-5/Diethylnitrosamine
Comments/Corrections
Comment In:
Hepatology. 2011 Aug;54(2):745; author reply 745-6   [PMID:  21563198 ]
Hepatology. 2011 Mar;53(3):1069   [PMID:  20967824 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tg...
Next Document:  Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus...